首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   190711篇
  免费   34793篇
  国内免费   2616篇
耳鼻咽喉   5521篇
儿科学   6544篇
妇产科学   3544篇
基础医学   8739篇
口腔科学   2381篇
临床医学   30774篇
内科学   55993篇
皮肤病学   8203篇
神经病学   19148篇
特种医学   7725篇
外科学   46229篇
综合类   401篇
现状与发展   72篇
一般理论   19篇
预防医学   10074篇
眼科学   4058篇
药学   3598篇
  1篇
中国医学   90篇
肿瘤学   15006篇
  2024年   551篇
  2023年   5136篇
  2022年   1812篇
  2021年   4732篇
  2020年   6931篇
  2019年   3549篇
  2018年   8930篇
  2017年   8393篇
  2016年   9587篇
  2015年   9799篇
  2014年   17373篇
  2013年   18005篇
  2012年   9184篇
  2011年   9174篇
  2010年   12141篇
  2009年   15871篇
  2008年   8709篇
  2007年   6851篇
  2006年   9030篇
  2005年   6293篇
  2004年   5136篇
  2003年   3883篇
  2002年   3756篇
  2001年   3982篇
  2000年   3130篇
  1999年   3400篇
  1998年   3902篇
  1997年   3658篇
  1996年   3536篇
  1995年   3360篇
  1994年   2076篇
  1993年   1673篇
  1992年   1446篇
  1991年   1473篇
  1990年   1110篇
  1989年   1212篇
  1988年   1044篇
  1987年   879篇
  1986年   911篇
  1985年   740篇
  1984年   579篇
  1983年   536篇
  1982年   548篇
  1981年   422篇
  1980年   379篇
  1979年   317篇
  1978年   339篇
  1977年   408篇
  1975年   283篇
  1972年   309篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
111.
112.
113.

Background

Radium 223 was introduced for metastatic castration-resistant prostate cancer based on the results of a randomized controlled trial showing risk reduction for death and skeletal events. Our aim was to evaluate the outcome of patients receiving radium 223 in a real-world setting.

Patients and Methods

We conducted a multicenter retrospective analysis in the Triveneto region of Italy.

Results

One hundred fifty-eight patients received radium 223 in our region. After a median follow-up of 9.5 months, 75 patients died. The median overall survival (OS) was 14.2 months, and the median progression-free survival (PFS) was 6.2 months. Seventy-one (45%) patients achieved progression as best response. Thirty-seven (23%) patients stopped the treatment early because of progression. Eastern Cooperative Oncology Group performance status was prognostic for OS (18.4 vs. 12.3 vs. 7.5 months; 0 vs. 1, P = .0062; 0 vs. 2, P = .0002), whereas previous prostatectomy or docetaxel exposure were not. A neutrophil to lymphocytes ratio ≥ 3 significantly impacted OS (18.1 vs. 9.7 months; P < .001) and slightly impacted PFS (6.6 vs. 5.6 months; P = .05). Patients with a baseline alkaline phosphatase (ALP) value ≥ 220 U/L had worse OS and PFS (24.1 vs. 10.5 months; 7.2 vs. 5.5 months; P < .001). Patients with changes in ALP value achieved better OS (P = .029) and PFS (P = .002). There was no difference according to the line of therapy (0 vs. ≥ 1; P = .490). The main grade 3/4 toxicities were anemia, asthenia, and thrombocytopenia.

Conclusion

This large real-world report confirms comparable OS and PFS data when compared with the pivotal study, as well as the predictive role of ALP and neutrophil to lymphocytes ratio. The definition of the optimal position of radium 223 in the treatment of metastatic castration-resistant prostate cancer has still to be defined.  相似文献   
114.
Marielle Kabbouche MD  FAHS 《Headache》2015,55(10):1426-1429
Status migrainosus is defined by the international classification of headache disorders (ICHD) criteria as a debilitating migraine lasting more then 72 hours. The epidemiology of status migrainosus is still unknown in adult and children, and frequently underdiagnosed. Children and adolescents often end up in the emergency room with an intractable headache that failed outpatient therapy. Six to seven percent of these children do not respond to acute infusion therapy and require hospitalization. It is imperative that more aggressive therapy is considered when patients are affected by a severe intractable headache to prevent further disability and returning the child to baseline activity. Multiple therapies are available for adults and children. Studies for acute therapy in the emergency room are available in adults and pediatric groups. Small studies are available for inpatient therapy in children and, along with available therapies for children and adolescents, are described in this review. A review of the literature shows growing evidence regarding the use of dihydroergotamine intravenously once patients are hospitalized. Effectiveness and safety have been proven in the last decades in adults and small studies in the pediatric populations.  相似文献   
115.
116.
117.
118.
119.
120.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号